Founded Date: 01 01 13
Last Funding Type: Series B
Headquarters: Cambridge, Massachusetts, United States
Investors Number: 7
Technology: Neurological Disorders
Employee Number: 101-250
Industry: Biotechnology, Health Care, Science and Engineering
Estimated Revenue: $10M to $50M
Last Funding Date: 13 04 15
Number Of Exists: Series B
Funding Status: IPO
Investor Type: Company
Investment Stage: N/A
Total Funding: 135000000